cbdMD, Inc. (YCBD) Return on equity 2016–2025
cbdMD, Inc. (YCBD) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-28.2%FY2025 · since FY2016: -1072.1% → -28.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -28.2% | +160.2 pp |
| FY2024 | -188.5% | +65.5 pp |
| FY2023 | -254.0% | -31.0 pp |
| FY2022 | -223.0% | -200.3 pp |
| FY2021 | -22.7% | -38.6 pp |
| FY2020 | 15.9% | +152.5 pp |
| FY2019 | -136.6% | -137.0 pp |
| FY2018 | 0.4% | +33.4 pp |
| FY2017 | -32.9% | +1039.2 pp |
| FY2016 | -1072.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice